|
1OQD
Crystal structure of sTALL-1 and BCMA
Deposited 2003-03-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 108
PDB declaration: 108-meric
|
Chain K
8–46(39 aa)
Fragment:extracellular domain
Chain L
8–46(39 aa)
Fragment:extracellular domain
Chain M
8–46(39 aa)
Fragment:extracellular domain
Chain N
8–46(39 aa)
Fragment:extracellular domain
Chain O
8–46(39 aa)
Fragment:extracellular domain
Chain P
8–46(39 aa)
Fragment:extracellular domain
Chain Q
8–46(39 aa)
Fragment:extracellular domain
Chain R
8–46(39 aa)
Fragment:extracellular domain
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 9;277 K;dioxane, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.60 Å
R-free 0.260
|
|
1XU2
The crystal structure of APRIL bound to BCMA
Deposited 2004-10-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain R
5–51(47 aa)
Fragment:BCMA ECD
Chain S
5–51(47 aa)
Fragment:BCMA ECD
Chain T
5–51(47 aa)
Fragment:BCMA ECD
|
Not recorded
|
NI NICKEL (II) ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;292 K;well solution: 0.1M MES, 5% Peg 8000, 10% Peg 1000, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 292K
|
Resolution 2.35 Å
R-free 0.213
|
|
2KN1
Solution NMR Structure of BCMA
Deposited 2009-08-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–50(49 aa)
Fragment:residues 2-50
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6;Ionic strength (raw mmCIF value) 10;Pressure ambient
NMR sample composition
900 uM BCMA, 10 mM sodium phosphate, 0.02 % sodium azide, 95% H2O, 5% D2O | 95% H2O/5% D2O
|
Resolution not provided
|
|
6J7W
Crystal Structure of Human BCMA in complex with UniAb(TM) VH
Deposited 2019-01-18
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
6–44(39 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;293 K;0.2M sodium malonate pH 4.0 and 20% PEG 3350
|
Resolution 2.60 Å
R-free 0.271
|
|
6J7W
Crystal Structure of Human BCMA in complex with UniAb(TM) VH
Deposited 2019-01-18
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
6–44(39 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;293 K;0.2M sodium malonate pH 4.0 and 20% PEG 3350
|
Resolution 2.60 Å
R-free 0.271
|
|
8HXQ
Nanobody1 in complex with human BCMA ECD
Deposited 2023-01-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–54(54 aa)
Chain D
1–54(54 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.1;293 K;0.2 M Ammonium sulfate, 20% w/v Polyethylene glycol 3350, pH6.1
|
Resolution 2.40 Å
R-free 0.274
|
|
8HXR
Nanobody2 in complex with human BCMA ECD
Deposited 2023-01-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–54(54 aa)
Chain D
1–54(54 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;1.8 M Sodium acetate trihydrate,
0.1 M Bis-Tris Propane pH7.0
|
Resolution 2.70 Å
R-free 0.287
|
|
8QY9
J22.9-H, fully humanized Fab Fragment based on chimeric J22.9-xi IgG against BCMA
Deposited 2023-10-25
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
7–41(35 aa)
|
Not recorded
|
CU COPPER (II) ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293.15 K;14% PEG 3350
100 mM BisTris
7.5 mM Cu(II)
|
Resolution 3.10 Å
R-free 0.301
|
|
8QYA
J22.9-FNY, fully humanized, CDR optimized Fab Fragment based on chimeric J22.9-xi IgG against BCMA; with VH CDR2 glycosylation
Deposited 2023-10-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
6–41(36 aa)
|
Not recorded
|
CU COPPER (II) ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;PEG 3350
CuCl2
BisTris
|
Resolution 2.72 Å
R-free 0.299
|
|
8QYB
J22.9-ISY, fully humanized and CDR optimized Fab Fragment based on chimeric J22.9-xi IgG against BCMA
Deposited 2023-10-25
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
7–41(35 aa)
|
Not recorded
|
CU COPPER (II) ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;14% PEG 3350
7.5 mM CuCl2
BisTris
|
Resolution 3.09 Å
R-free 0.288
|
|
9MQO
Crystal structure of BCMA in complex with CA10v2 Fab
Deposited 2025-01-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 18
PDB declaration: 18-meric
|
Chain A
1–54(54 aa)
Chain D
1–54(54 aa)
Chain G
1–54(54 aa)
Chain J
1–54(54 aa)
Chain M
1–54(54 aa)
Chain P
1–54(54 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.18 M Sodium Chloride, 0.09 M
Phosphate/citrate pH 4.2, 20 % w/v PEG 8000, 0.1M Sodium Malonate
|
Resolution 3.18 Å
R-free 0.272
|